Publications by authors named "Bethany Kausch"
Article Synopsis
- This text refers to a correction made to an article identified by its DOI (Digital Object Identifier) number: 10.1186/1710-1492-10-1.
- The correction likely addresses errors or inaccuracies in the original publication.
- Such corrections are important for maintaining the integrity and accuracy of academic research.
Article Synopsis
- Up to 30% of food allergy patients react to multiple allergens, and while there's no current cure, oral immunotherapy (OIT) with omalizumab shows promise in enhancing tolerance to larger amounts of food proteins.
- The study enrolled 25 participants with multiple food allergies, administering omalizumab before and after OIT; most tolerated increased allergen doses with minimal severe reactions.
- Results indicate that OIT with omalizumab can enable faster desensitization for multiple foods, warranting further research through Phase 2 trials to establish safety and efficacy.
Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.
Allergy Asthma Clin Immunol
January 2014
Background: Thirty percent of children with food allergy are allergic to more than one food. Previous studies on oral immunotherapy (OIT) for food allergy have focused on the administration of a single allergen at the time. This study aimed at evaluating the safety of a modified OIT protocol using multiple foods at one time.
View Article and Find Full Text PDF